FDA delays decision on GSK blood cancer drug at heart of $1.9B Sierra Oncology deal

[anonymous]

Ru Roh! This not good. Thanks for bailing out my Sierra stock though. Idiots.

 

[anonymous]

What was the issue? Was it not killing enough people?

 

[anonymous]

And so they are doing — they are doing the examinations now — the testing now, and making the decision now. When they are ready, when they’ve done all the scientific need to be done to determine children at ages 3, 4, 5, 6, 7 and 8, they, in fact, are — all have different makeups. They’re developing. They’re trying to figure out whether or not there’s a vaccination that would affect one child that’s at such and such an age and not another child. That’s underway. Just like the other question, there’s a logical — and I’ve heard you speak about it because you always — I’m not being solicitous, but you — you’re always straight up about what you’re doing.

 

[anonymous]

So happy that I was retained after Blenrep fiasco. The future still looks bright.